Teranar Tablet 2 Mg

Teranar Tablet 2 mg contains terazosin hydrochloride equivalent to 2 mg of terazosin as its active ingredient. Terazosin is a well-established medication primarily used for the treatment of benign prostatic hyperplasia (BPH) and hypertension (high blood pressure). Below is a detailed narrative on its pharmacology, uses, dosage, side effects, and other relevant clinical information.

Introduction to Terazosin

Terazosin is an alpha-1 adrenergic receptor antagonist belonging to the quinazoline chemical class. It selectively blocks alpha-1 receptors located on vascular smooth muscle and the smooth muscle of the prostate and bladder neck. This blockade results in muscle relaxation, which helps alleviate urinary symptoms related to BPH and reduces vascular resistance to lower blood pressure.

Therapeutic Uses

Benign Prostatic Hyperplasia (BPH)

BPH is a non-cancerous enlargement of the prostate gland causing urinary difficulties such as hesitancy, weak stream, incomplete bladder emptying, urgency, and frequency. Terazosin relaxes the smooth muscles in the prostate and bladder neck, improving urine flow and reducing BPH symptoms.

Hypertension

Terazosin is also indicated for the management of essential hypertension. By relaxing vascular smooth muscle, it dilates blood vessels, thereby lowering peripheral resistance and blood pressure. This helps prevent complications of uncontrolled hypertension such as heart disease, stroke, and kidney damage.

Off-Label and Investigational Uses

Research is ongoing into additional uses of terazosin, including:

• Alleviation of nightmares in post-traumatic stress disorder (PTSD)

• Treatment of hyperhidrosis related to certain antidepressants

• Management of chronic prostatitis and pelvic pain syndrome

• Potential benefits in urethritis after radiation therapy and idiopathic oligozoospermia

Pharmacodynamics and Mechanism of Action

Terazosin competitively antagonizes post-synaptic alpha-1 adrenergic receptors, particularly alpha-1A receptors predominant in the prostate and bladder neck. This leads to smooth muscle relaxation, reducing urethral resistance and improving urinary flow in BPH patients. The antihypertensive effect is due to vasodilation from alpha-1 blockade in arterioles, lowering systemic vascular resistance and blood pressure.

Additionally, terazosin may induce apoptosis in prostate cells via upregulation of transforming growth factor beta-1 (TGF-beta1) and caspase pathways, contributing to its therapeutic effects in BPH.

Dosage and Administration

Terazosin is available as oral capsules, including the 2 mg strength found in Teranar tablets. The usual adult dosage ranges from 1 mg to 10 mg daily, often starting at a low dose to minimize side effects, especially orthostatic hypotension. It is typically taken once daily at bedtime, with or without food. Dosage adjustments are made based on clinical response and tolerability.

Patients should continue therapy even if symptoms improve and consult their healthcare provider before discontinuing the medication.

Side Effects and Precautions

Common Side Effects

• Dizziness or lightheadedness, especially when standing up quickly (orthostatic hypotension)

• Fatigue

• Headache

• Nasal congestion

• Weakness

Serious but Less Common Effects

• Fainting due to blood pressure drop

• Palpitations

• Priapism (prolonged erection)

Patients should be monitored for hypotension and advised to rise slowly from sitting or lying positions. Caution is advised in patients with a history of low blood pressure or those taking other antihypertensive agents.

Storage and Handling

Terazosin capsules should be stored at room temperature between 20°C to 25°C (68°F to 77°F), protected from moisture and direct sunlight. Short-term exposure to temperatures between 15°C to 30°C (59°F to 86°F) is acceptable during transport.

Summary Table: Teranar Tablet 2 mg (Terazosin Hydrochloride)

Teranar Tablet 2 mg, containing terazosin hydrochloride, is an effective medication for managing symptoms of BPH and hypertension through its alpha-1 blocking activity. Proper dosing, monitoring for side effects, and adherence to therapy are essential for optimal outcomes. Always consult a healthcare provider for personalized medical advice and before making any changes to medication regimens.